Rockwell Medical stockholders approve reverse stock split, elect directors

ROCKWELL MEDICAL, INC.

Reverse stock split amendment approved: 16,993,038 for, 6,597,036 against, 223,632 abstain.
Class II directors Joseph Dawson and Joan Lau reelected with 9.8M and 9.9M votes for, respectively.
Advisory vote on executive compensation passed: 8,232,918 for, 2,682,354 against, 96,595 abstain.
Ratification of EisnerAmper LLP as auditor for 2026 approved: 22,996,530 for, 698,744 against.
Reverse stock split intended to regain compliance with Nasdaq minimum bid price requirement.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ROCKWELL MEDICAL, INC. shareholders approved To elect the two Class II directors to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified. at the 2026-06-12 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-12

Exact text from the filing

Proposal One: To elect the two Class II directors to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified. For Against Abstain Broker Non-Votes Joseph Dawson 9,812,114 869,022 330,731 12,801,839 Joan Lau, Ph.D. 9,890,379 729,615 391,873 12,801,839

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ROCKWELL MEDICAL, INC. shareholders approved To approve and adopt an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of the Company’s common stock. at the 2026-06-12 meeting.

Proposal: reverse split
Outcome: passed
Meeting: 2026-06-12

Exact text from the filing

Proposal Four: To approve and adopt an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of the Company’s common stock. For Against Abstain 16,993,038 6,597,036 223,632

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ROCKWELL MEDICAL, INC. shareholders approved To ratify the selection of EisnerAmper LLP as the Company’s independent registered public accounting firm for 2026. at the 2026-06-12 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-12

Exact text from the filing

Proposal Three: To ratify the selection of EisnerAmper LLP as the Company’s independent registered public accounting firm for 2026. For Against Abstain 22,996,530 698,744 118,432

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ROCKWELL MEDICAL, INC. shareholders approved To approve, on an advisory basis, the compensation of the Company's named executive officers. at the 2026-06-12 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-06-12

Exact text from the filing

Proposal Two: To approve, on an advisory basis, the compensation of the Company's named executive officers. For Against Abstain Broker Non-Votes 8,232,918 2,682,354 96,595 12,801,839

View on SEC.gov

1639 shareholder votes filed in the last 30 days. Browse all shareholder votes →

ROCKWELL MEDICAL, INC. filing history →

Source: SEC EDGAR

accession 0001628280-26-043210

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.